HIGHLIGHTS
- who: Revised November and colleagues from the Paris , France have published the Article: 1874-091X/21 Send Orders for Reprints to reprints, in the Journal: (JOURNAL) of November/21,/2020
- what: The authors propose to reposition the macrolides (azithromycin or erythromycin or others) and tetracyclines for the treatment of COVID-19 patients on account of the following data gathered in this report. Fourth zinc cations were previously shown to be a strong antiviral agent while all the macrolides and tetracyclines that the authors propose for repurposing or repositioning to cure the COVID-19 are shown . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.